Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 8,613 | 8,842 | 8,990 | 3,404 | 8,811 |
| Cost of Goods | 3,357 | 2,339 | 2,116 | -1,469 | 3,204 |
| Gross Profit | 5,256 | 6,503 | 6,874 | 4,873 | 5,607 |
| Operating Expenses | 10,443 | 10,412 | 11,646 | 14,551 | 13,161 |
| Operating Income | -4,830 | -3,570 | -4,656 | -10,148 | -7,350 |
| Interest Expense | 588 | 180 | 7 | 0 | 0 |
| Other Income | 2,650 | -544 | -1,426 | 2,760 | -1,843 |
| Pre-tax Income | -2,768 | -4,294 | -6,089 | -7,388 | -9,194 |
| Net Income Continuous | -2,768 | -4,294 | -6,089 | -6,574 | -9,194 |
| Net Income | $-2,768 | $-4,294 | $-6,089 | $-6,574 | $-9,194 |
| EPS Basic Total Ops | -0.05 | -0.08 | -0.11 | -0.13 | -0.21 |
| EPS Basic Continuous Ops | -0.05 | -0.08 | -0.11 | -0.14 | -0.21 |
| EPS Diluted Total Ops | -0.05 | -0.08 | -0.11 | -0.13 | -0.21 |
| EPS Diluted Continuous Ops | -0.05 | -0.08 | -0.11 | -0.14 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.08 | -0.12 | N/A | N/A |
| EBITDA(a) | $-4,211 | $-3,123 | $-4,213 | $-9,358 | $-6,888 |